Search Results Search Sort by RelevanceMost Recent Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175. Medicine and Society Aug 2022 Clinicians’ Racial Biases as Pathways to Iatrogenic Harms for Black People Keisha Ray, PhD Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm. AMA J Ethics. 2022;24(8):E768-772. doi: 10.1001/amajethics.2022.768. Podcast Dec 2016 Ethics Talk: The Limits and Possibilities of Biomedical Enhancement - An Interview with Dr. Allen Buchanan This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.
Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175.
Medicine and Society Aug 2022 Clinicians’ Racial Biases as Pathways to Iatrogenic Harms for Black People Keisha Ray, PhD Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm. AMA J Ethics. 2022;24(8):E768-772. doi: 10.1001/amajethics.2022.768.
Podcast Dec 2016 Ethics Talk: The Limits and Possibilities of Biomedical Enhancement - An Interview with Dr. Allen Buchanan This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.